Circulating long chain acylcarnitines and outcomes in diabetic heart failure: an HF-ACTION clinical trial substudy

Circulating long chain acylcarnitines and outcomes in diabetic heart failure: an HF-ACTION clinical trial substudy

Abstract Background Whether differences in circulating long chain acylcarnitines (LCAC) are seen in heart failure (HF) patients with and without diabetes mellitus (DM), and whether these biomarkers report on exercise capacity and clinical outcomes, remains unknown. The objective of the current study...

Full description

Bibliographic Details
Main Authors: Lauren K. Truby, Jessica A. Regan, Stephanie N. Giamberardino, Olga Ilkayeva, James Bain, Christopher B. Newgard, Christopher M. O’Connor, G. Michael Felker, William E. Kraus, Robert W. McGarrah, Svati H. Shah
Format: Article
Language:English
Published: BMC 2021-08-01
Series:Cardiovascular Diabetology
Subjects:
Heart failure
Diabetes
Exercise
Long chain acylcarnitines
Online Access:https://doi.org/10.1186/s12933-021-01353-z

Internet

https://doi.org/10.1186/s12933-021-01353-z

Similar Items